The Wall Street Journal Vs. Zoetis

Back in April, the Wall Street Journal released an incendiary article on the side effects of Librela, Zoetis Inc.'s (NYSE: ZTS ) OA (Osteoarthritis) pain MAB used in dogs. The article claimed that Librela has had dangerousBest Anchor Stocks helps you find the best quality stocks to outperform the market with the lowest volatility/growth ratio. We look for top-notch quality compounders, with solid growth and lower volatility than you would expect.Best Anchor Stocks picks have a track record of revenue growth ...